계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Artizan Biosciences
company
About
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $12M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Artizan Biosciences provides pharmaceutical drug development services, namely, the development of small molecule drugs for use in humans. The Durham-based biotech company declined to disclose its intended use of the proceeds from this offering, as well as its current revenue range.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$12M
Artizan Biosciences has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
Jun 11, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 11, 2019 | Series A | $12M | 1 | — | — | Detail |
| Feb 6, 2017 | Series Unknown | — | 1 |
Malin Corporation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Artizan Biosciences is funded by 2 investors.
Malin Corporation
and Marin Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Malin Corporation
|
Yes | Series Unknown |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
